广药集团揭牌成立两家专业化平台公司

Group 1 - The establishment of Guangzhou Pharmaceutical Digital Technology Co., Ltd. and Guangzhou Pharmaceutical Industry Operation Management Co., Ltd. marks a significant step for Guangzhou Pharmaceutical Group in deepening state-owned enterprise reform, optimizing resource allocation, and accelerating digital transformation [1][2] - Guangzhou Pharmaceutical Digital Technology Co., Ltd. aims to focus on digital solutions for the pharmaceutical industry and AI-driven pharmaceutical research and development, leveraging its advantages in artificial intelligence, computing infrastructure, and public data operations [1] - The company plans to implement its digital transformation strategy by integrating internal and external data assets and applying AI in drug research, production, and marketing, thereby driving intelligent transformation across various business sectors [1] Group 2 - Guangzhou Pharmaceutical Industry Operation Management Co., Ltd. is designed as a specialized asset management and engineering construction platform, focusing on revitalizing existing assets and efficiently advancing engineering projects [2] - The company will establish a dynamic management system to oversee asset revitalization, resolve historical issues, and address safety hazards, while managing significant construction projects in a centralized and professional manner [2] - The dual strategic significance of the new companies includes freeing production enterprises from non-core asset management to focus on technological innovation and market expansion, and transforming existing resources into capital and intelligence to support core business development [2]